These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12483537)

  • 41. Characterization of novel inhibitors of cyclin-dependent kinases.
    Kent LL; Hull-Campbell NE; Lau T; Wu JC; Thompson SA; Nori M
    Biochem Biophys Res Commun; 1999 Jul; 260(3):768-74. PubMed ID: 10403840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression.
    Ko TC; Yu W; Sakai T; Sheng H; Shao J; Beauchamp RD; Thompson EA
    Oncogene; 1998 Jul; 16(26):3445-54. PubMed ID: 9692552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
    Li Y; Glozak MA; Smith SM; Rogers MB
    Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
    Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
    Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
    Liu Q; Loo WT; Sze SC; Tong Y
    Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53.
    Kim AL; Athar M; Bickers DR; Gautier J
    J Invest Dermatol; 2002 May; 118(5):818-24. PubMed ID: 11982759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
    Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
    J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
    Liu W; Sun M; Jiang J; Shen X; Sun Q; Liu W; Shen H; Gu J
    Biochem Biophys Res Commun; 2004 Sep; 321(4):954-60. PubMed ID: 15358120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitex rotundifolia Fruit Suppresses the Proliferation of Human Colorectal Cancer Cells through Down-regulation of Cyclin D1 and CDK4 via Proteasomal-Dependent Degradation and Transcriptional Inhibition.
    Song HM; Park GH; Park SB; Kim HS; Son HJ; Um Y; Jeong JB
    Am J Chin Med; 2018; 46(1):191-207. PubMed ID: 29298515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
    Kim YC; Chen C; Bolton EC
    PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cdk4/cyclin D1 kinase, a universal and critical regulator of apoptosis.
    Katayama K; Dobashi Y; Kitagawa M; Kawai M; Kadoya Y; Kameya T
    Anticancer Res; 2003; 23(1A):235-43. PubMed ID: 12680219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.
    Das SK; Hashimoto T; Kanazawa K
    Biochim Biophys Acta; 2008 Apr; 1780(4):743-9. PubMed ID: 18230364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo.
    Nelsen CJ; Rickheim DG; Timchenko NA; Stanley MW; Albrecht JH
    Cancer Res; 2001 Dec; 61(23):8564-8. PubMed ID: 11731443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.
    Klier M; Anastasov N; Hermann A; Meindl T; Angermeier D; Raffeld M; Fend F; Quintanilla-Martinez L
    Leukemia; 2008 Nov; 22(11):2097-105. PubMed ID: 18685613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermal growth factor and transforming growth factor-alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice.
    Ramljak D; Jones AB; Diwan BA; Perantoni AO; Hochadel JF; Anderson LM
    Cancer Res; 1998 Aug; 58(16):3590-7. PubMed ID: 9721866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
    Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
    Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
    Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
    Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00.
    Joshi KS; Rathos MJ; Joshi RD; Sivakumar M; Mascarenhas M; Kamble S; Lal B; Sharma S
    Mol Cancer Ther; 2007 Mar; 6(3):918-25. PubMed ID: 17363486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.